Monte Rosa Therapeutics
Price & Volume
Stats
See more52W Range | $8.94-$25.77 |
Market Cap | $878.7M |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $28.7M |
Revenue Growth (YoY) | -61.3% |
Gross Profit (12 Mos) | -$133.6M |
Diluted EPS | -$1.75 |
News
See moreYahoo Finance • 30 days ago
Novartis (NVS) Just Handed Monte Rosa (GLUE) A $50M Milestone
Yahoo Finance • last month
Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon
Yahoo Finance • last month
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Yahoo Finance • 2 months ago
Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
About
CEO | Dr. Markus Warmuth M.D. |
Address | 321 Harrison Avenue, Boston, MA, United States, 02118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 173 |